Concepedia

Author

J. A. Barranger

National Institutes of Health

Also Known As

J A Barranger, J BARRANGER, J Barranger, J. A. Barranger, J. Barranger, J.A. BARRANGER, J.A. Barranger, JA Barranger

64

Publications

2.6K

Citations

28

H-Index

96

Concepts

All Affiliations

National Institutes of HealthUniversity of AmsterdamNational Institute of Neurological Disorders and StrokeUniversity of PittsburghCentro de Genética Clínica
JA

About

J. A. Barranger is an author at National Institutes of Health specializing in medicine, glycobiology, and biochemistry.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

17

23

1.3K

2

Natural Sciences

8

8

512

3

Engineering

2

2

173

4

Health Sciences

2

2

111

5

Public Health

1

1

188

J. A. Barranger

×

35

Publications

2.4K

Citations

26

H-Index

YearCitations

Genetic heterogeneity in type 1 Gaucher disease: multiple genotypes in Ashkenazic and non-Ashkenazic individuals.

Shoji Tsuji, B M Martin, J. A. Barranger,

Proceedings of the National Academy of Sciences

1988

188

Biosynthesis of the lysosomal enzyme glucocerebrosidase.

Ann H. Erickson, Edward I. Ginns, J. A. Barranger

Journal of Biological Chemistry

1985

138

Improvement of bone disease by imiglucerase (Cerezyme) therapy in patients with skeletal manifestations of type 1 Gaucher disease: results of a 48‐month longitudinal cohort study

KB Sims, GM Pastores, NJ Weinreb,

Clinical Genetics

2008

133

Nucleotide sequence of cDNA containing the complete coding sequence for human lysosomal glucocerebrosidase.

Shoji Tsuji, Prabhakara V. Choudary, Brian M. Martin,

Journal of Biological Chemistry

1986

128

Structure of the N-asparagine-linked oligosaccharide units of human placental beta-glucocerebrosidase.

S. Takasaki, Gary J. Murray, F S Furbish,

Journal of Biological Chemistry

1984

126

Mutations of glucocerebrosidase: discrimination of neurologic and non-neurologic phenotypes of Gaucher disease.

Edward I. Ginns, Roscoe O. Brady, Samuel J. Pirruccello,

Proceedings of the National Academy of Sciences

1982

120

Gene mapping and leader polypeptide sequence of human glucocerebrosidase: implications for Gaucher disease.

Edward I. Ginns, Prabhakara V. Choudary, Shoji Tsuji,

Proceedings of the National Academy of Sciences

1985

116

Assignment of the gene coding for human β-glucocerebrosidase to the region q21-q31 of chromosome 1 using monoclonal antibodies

R. A. Barneveld, W. Keiizer, F. P. W. Tegelaers,

Human Genetics

1983

111

Imiglucerase (Cerezyme<sup>®</sup>) improves quality of life in patients with skeletal manifestations of Gaucher disease

Neal J. Weinreb, J. A. Barranger, Seymour Packman,

Clinical Genetics

2007

103

Liver abnormalities in patients with Gaucher's disease

S. P. James, F. Wayne Stromeyer, Chi‐Wen Chang,

Gastroenterology

1981

100

Page 1